Pharmosa Biopharm Inc Sustainability Reports
Pharmosa Biopharm Inc. is a clinical-stage biotechnology company focused on developing new drug-device combination products. It leverages proprietary liposomal formulation and sustained-release delivery technologies for therapies primarily targeting pulmonary arterial hypertension.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG015CHM0L8
4 reports from 2021 to 2025
